Literature DB >> 10347162

Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects.

F R Sallmann1, S Baveye-Descamps, F Pattus, V Salmon, N Branza, G Spik, D Legrand.   

Abstract

The binding of lactoferrin, an iron-binding glycoprotein found in secretions and leukocytes, to the outer membrane of Gram-negative bacteria is a prerequisite to exert its bactericidal activity. It was proposed that porins, in addition to lipopolysaccharides, are responsible for this binding. We studied the interactions of human lactoferrin with the three major porins of Escherichia coli OmpC, OmpF, and PhoE. Binding experiments were performed on both purified porins and porin-deficient E. coli K12 isogenic mutants. We determined that lactoferrin binds to the purified native OmpC or PhoE trimer with molar ratios of 1.9 +/- 0.4 and 1.8 +/- 0.3 and Kd values of 39 +/- 18 and 103 +/- 15 nM, respectively, but not to OmpF. Furthermore, preferential binding of lactoferrin was observed on strains that express either OmpC or PhoE. It was also demonstrated that residues 1-5, 28-34, and 39-42 of lactoferrin interact with porins. Based on sequence comparisons, the involvement of lactoferrin amino acid residues and porin loops in the interactions is discussed. The relationships between binding and antibacterial activity of the protein were studied using E. coli mutants and planar lipid bilayers. Electrophysiological studies revealed that lactoferrin can act as a blocking agent for OmpC but not for PhoE or OmpF. However, a total inhibition of the growth was only observed for the PhoE-expressing strain (minimal inhibitory concentration of lactoferrin was 2.4 mg/ml). These data support the proposal that the antibacterial activity of lactoferrin may depend, at least in part, on its ability to bind to porins, thus modifying the stability and/or the permeability of the bacterial outer membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347162     DOI: 10.1074/jbc.274.23.16107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes.

Authors:  Marcus Thein; Ignas Bunikis; Katrin Denker; Christer Larsson; Sally Cutler; Michel Drancourt; Tom G Schwan; Reinhard Mentele; Friedrich Lottspeich; Sven Bergström; Roland Benz
Journal:  J Bacteriol       Date:  2008-08-29       Impact factor: 3.490

2.  Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.

Authors:  Howard N Hunter; A Ross Demcoe; Håvard Jenssen; Tore J Gutteberg; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.

Authors:  Henry F Gomez; Theresa J Ochoa; Irene Herrera-Insua; Lily G Carlin; Thomas G Cleary
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  The Pepsin Hydrolysate of Bovine Lactoferrin Causes a Collapse of the Membrane Potential in Escherichia coli O157:H7.

Authors:  Christopher Murdock; Michael L Chikindas; Karl R Matthews
Journal:  Probiotics Antimicrob Proteins       Date:  2010-06       Impact factor: 4.609

5.  Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity.

Authors:  Yi-Fang Liu; Jing-Jou Yan; Huan-Yao Lei; Ching-Hao Teng; Ming-Cheng Wang; Chin-Chung Tseng; Jiunn-Jong Wu
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

6.  Elimination of channel-forming activity by insertional inactivation of the p13 gene in Borrelia burgdorferi.

Authors:  Yngve Ostberg; Marija Pinne; Roland Benz; Patricia Rosa; Sven Bergström
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

7.  One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Authors:  Kabilan Velliyagounder; Jeffrey B Kaplan; David Furgang; Diana Legarda; Gill Diamond; Ruth E Parkin; Daniel H Fine
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  High-resolution diffraction from crystals of a membrane-protein complex: bacterial outer membrane protein OmpC complexed with the antibacterial eukaryotic protein lactoferrin.

Authors:  N Sundara Baalaji; K Ravi Acharya; T P Singh; S Krishnaswamy
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-07-30

9.  Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity.

Authors:  Mónica Viejo-Díaz; María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Growth of Yersinia pseudotuberculosis in human plasma: impacts on virulence and metabolic gene expression.

Authors:  Marie-Laure Rosso; Sylvie Chauvaux; Rodrigue Dessein; Caroline Laurans; Lionel Frangeul; Céline Lacroix; Angèle Schiavo; Marie-Agnès Dillies; Jeannine Foulon; Jean-Yves Coppée; Claudine Médigue; Elisabeth Carniel; Michel Simonet; Michaël Marceau
Journal:  BMC Microbiol       Date:  2008-12-03       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.